HKU Scholars Hub: Browsing DSpace

Browsing by Author Ip, HW

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 18 of 18

	Title	Author(s)	Issue Date	Views
	Acquired factor VIII inhibitor and positive lupus anticoagulant testing on silica clotting time Journal:International Journal of Laboratory Hematology	Ip, HW So, JCC Leung, RYY Chan, JY Sin, P Lam, CCK	2015	65
	ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis Proceeding/Conference:Blood	Au Yeung, KHR Russel, V Choi, WL Wong, A Tsui, L Lee, YYC Li, J Singh, GHH Ip, HW Kwong, YL Dave, T Ondrejka, SL Bhagat, G Chadburn, A Rutherford, SC Koff, JL Jaye, DL Czader, M Louissaint, A Li, S Xu, J Yin, CC Ong, CK Cheng, CL Behdad, A Evens, AM Norgaard, PH Gang, AO Leppa, S Karjalainen-Lindsberg, ML Chapman, JR Amador, C Iqbal, J Fedoriw, Y Bogusz, AM Evans, AG Juskevicius, R Hsi, ED Naresh, KN Dave, SS Tse, EWC	2021	30
	Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-Like Tyrosine Kinase-3 internal tandem duplication positive acute myeloid leukemia Journal:Haematologica	Singh, GHH Man, CH Ip, HW Choi, WL Chow, HCH Kwong, YL Leung, AYH	2015	93
	Clofarabine, Cytarabine And Mitoxantrone (CLAM) for relapsed or refractory acute myeloid leukaemia - interim results of a prospective phase 2 study Proceeding/Conference:Congress of the European Haematology Association	Singh, GHH Ip, HW Yip, SF Kho, CSB Lee, KKH Mak, V Lau, JSM Lau, CK Lin, SY Wong, SMR Li, W Kwong, YL	2017	254
	Deep molecular response in chronic myelogenous leukemia: ensuring accuracy and consistency Journal:Leukemia	Ip, HW So, JCC	2015	56
	Diagnosis and prevention of thalassemia Journal:Critical Reviews in Clinical Laboratory Sciences	Ip, HW So, JCC	2013	82
	Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations Journal:American Journal of Hematology	Leung, GMK Zhang, C Ng, NKL Yang, N Lam, SSY Au, CH Chan, TL Ma, ESK Tsui, SP Ip, HW So, JCC Ng, MHL Cheng, KCK Wong, KF Siu, LLP Yip, SF Lin , SY Lau, JSM Luk , TH Lee , HKK Lau, CK Kho, B Kwong, YL Leung, AYH	2019	66
	Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms Journal:Journal of Clinical Pathology	Malherbe, JA Fuller, KA Mirzai, B Kavanagh, S So, JCC Ip, HW Guo, BB Forsyth, C Howman, R Erber, WN	2016	101
	FLT3 internal tandem duplication in acute promyelocytic leukemia: central nervous system relapse Journal:Annals of Hematology	Singh, GHH Ip, HW Pang, AWK Sum, CY Leung, AYH Kwong, YL	2015	172
	Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia Journal:Science Translational Medicine	Lam, SY Ho, SK He, B Wong, WW Cher, CY Ng, KL Man, CH Singh, GHH Cheung, MS Ip, HW So, JCC Tamburini, J So, CWE Ho, DN Au, CH Chan, TL Ma, ESK Liang, RHS Kwong, YL Leung, AYH	2016	184
	Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study Journal:Cancer	Singh, GHH Yim, RLH Lee, HKK Mak, V Lin, SY Kho, B Yip, SF Lau, JSM Li, W Ip, HW Hwang, YYG Chan, SYT Tse, EWC Au, WY Kumana, CR Kwong, YL	2018	147
	Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting Journal:Hematology	Gill, H Leung, GMK Yim, R Lee, P Pang, HH Ip, HW Leung, RYY Li, J Panagiotou, G Ma, ESK Kwong, YL	2020	56
	Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosis Journal:Annals of Hematology	Singh, GHH Ip, HW Yim, RLH Tang, WF Pang, HMH Lee, P Leung, GMK Li, JWY Tang, K So, JCC Leung, RYY Li, J Panagiotou, I Lam, CCK Kwong, YL	2019	96
	Next-Generation Sequencing with a 54-Gene Panel Identifies Unique Mutational Profile and Prognostic Markers in Chinese Patients with Myelofibrosis Proceeding/Conference:Blood	Singh, GHH Ip, HW Yim, RLH Tang, TWF Pang, HMH Lee, P Leung, GMK Li, JWY Tang, K So, JCC Leung, RYY Li, J Panagiotou, I Lam, CCK Kwong, YL	2017	142
	Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study Journal:Cancer	Singh, GHH Kumana, CR Yim, RLH Hwang, YYG Chan, SYT Yip, SF Lee, HKK Mak, V Lau, JSM Chan, CC Kho, B Wong, RSM Li, W Lin, SY Lau, CK Ip, HW Leung, RYY Lam, CCK Kwong, YL	2019	67
	Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults Journal:Blood Cancer Journal	Tsui, SP Ip, HW Saw, NY Zhang, C Cheung, AK Ng, NK Man, CH Lam, SS Tang, WF Lin, CH Cheng, GH Au, CH Ma, ES Chan, TL So, JC Ng, MH Cheng, KC Wong, KF Siu, LP Yip, SF Lin, SY Lau, JS Luk, TH Lee, HK Lau, CK Kho, B Sim, JP Kwong, YL Leung, SY Javed, A Leung, AY	2020	112
	Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3 Journal:Cancer	Zhang, C Lam, SSY Leung, GMK Tsui, SP Yang, N Ng, NKL Ip, HW Au, CH Chan, TL Ma, ESK Yip, SF Lee, HKK Lau, JSM Luk, TH Li, W Kwong, YL Leung, AYH	2020	40
	Whole exome sequencing identifies novel mutations in relapsed or refractory acute promyelocytic leukaemia failing treatment with oral arsenic trioxide Proceeding/Conference:Congress of the European Hematology Association, EHA 2016	Singh, GHH Ip, HW Li, J Yim, RLH Panagiotou, G Leung, AYH Kwong, YL	2016	78

Showing results 1 to 18 of 18